Injective and Espresso Systems collaborate to create decentralized savings systems

Injective and Espresso Systems have announced a collaboration to create decentralized savings systems. This collaboration marks an important step towards decentralizing the savings systems built within the Injective ecosystem, most notably Cascade, the first ever Solana SVM savings suite for Injective and the broader IBC ecosystem.

What is Espresso Systems?

Espresso Systems builds tools and infrastructure that create more secure, open and efficient options for network interactions and transactions. Its core service offering is the Espresso Sequencer, which plays a critical role in enabling decentralized federation and improved interoperability in the context of Tier 2 scaling solutions.

It is designed to provide fast and efficient transaction processing while maintaining a decentralized approach that provides robust neutrality, security and fairness in the transaction validation process. The sequencer achieves this without compromising the user experience typically associated with systems with a single centralized sequencer. Espresso Systems is backed by some of the leading firms in the industry such as Electric Capital, Greylock Partners, Sequoia Capital and Polychain Capital.

How does this affect the Injective community?

Espresso's shared sequencer solution plays a critical role in providing decentralized pooling and improved interoperability without sacrificing the fast user interaction provided by a single centralized sequencer. In addition, the Espresso platform provides storage packages with scalable data availability, offering a cost-effective and decentralized data availability (DA) solution with strong guarantees.

The first milestone in the collaboration will be the integration of the test network with Cascade, which will be a major milestone in Injective's journey to deliver fully decentralized sequencer frameworks for Injective's accumulation packages without sacrificing the incredibly high speeds our users have come to rely on. Following the successful completion of the testing phase, the main network deployment will begin in early 2024. Future users of cumulative packets on Injective can expect exceptionally low latency while maintaining confidence that their transactions are processed in a decentralized, censorship-resistant, and fair manner.

Conclusions

The collaboration between Injective and Espresso Systems is an important step towards more decentralized and scalable savings systems. This collaboration will contribute to the further growth and development of the Injective ecosystem.

Injective and Espresso Systems collaborate to create decentralized savings systems

Injective and Espresso Systems have announced a collaboration to create decentralized savings systems. This collaboration marks an important step towards decentralizing the savings systems built within the Injective ecosystem, most notably Cascade, the first ever Solana SVM savings suite for Injective and the broader IBC ecosystem.

What is Espresso Systems?

Espresso Systems builds tools and infrastructure that create more secure, open and efficient options for network interactions and transactions. Its core service offering is the Espresso Sequencer, which plays a critical role in enabling decentralized federation and improved interoperability in the context of Tier 2 scaling solutions.

It is designed to provide fast and efficient transaction processing while maintaining a decentralized approach that provides robust neutrality, security and fairness in the transaction validation process. The sequencer achieves this without compromising the user experience typically associated with systems with a single centralized sequencer. Espresso Systems is backed by some of the leading firms in the industry such as Electric Capital, Greylock Partners, Sequoia Capital and Polychain Capital.

How does this affect the Injective community?

Espresso's shared sequencer solution plays a critical role in providing decentralized pooling and improved interoperability without sacrificing the fast user interaction provided by a single centralized sequencer. In addition, the Espresso platform provides storage packages with scalable data availability, offering a cost-effective and decentralized data availability (DA) solution with strong guarantees.

The first milestone in the collaboration will be the integration of the test network with Cascade, which will be a major milestone in Injective's journey to deliver fully decentralized sequencer frameworks for Injective's accumulation packages without sacrificing the incredibly high speeds our users have come to rely on. Following the successful completion of the testing phase, the main network deployment will begin in early 2024. Future users of cumulative packets on Injective can expect exceptionally low latency while maintaining confidence that their transactions are processed in a decentralized, censorship-resistant, and fair manner.

Conclusions

The collaboration between Injective and Espresso Systems is an important step towards more decentralized and scalable savings systems. This collaboration will contribute to the further growth and development of the Injective ecosystem.